Cytokine profiling in pulmonary arterial hypertension: the role of redox homeostasis and sex

被引:8
作者
Rafikov, Ruslan
Rischard, Franz
Vasilyev, Mikhail
Varghese, Mathews V.
Yuan, Jason X-J
Desai, Ankit A.
Garcia, Joe G. N.
Rafikova, Olga
机构
[1] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85724 USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[3] Indiana Univ, Dept Med, Indianapolis, IN USA
关键词
GROUP BOX 1; OXIDATIVE STRESS; T-CELLS; INTERLEUKIN-6; NECROSIS; INFLAMMATION; SURVIVAL; DISEASES; MARKERS; FEMALE;
D O I
10.1016/j.trsl.2022.03.013
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Pulmonary arterial hypertension (PAH) is a fatal disease with a well-established sexual dimorphism. Activated inflammatory response and altered redox homeostasis, both known to manifest in a sex-specific manner, are implicated in the pathogenic mecha-nisms involved in PAH development. This study aimed to evaluate the impact of sex and plasma redox status on circulating cytokine profiles. Plasma oxidation-reduction poten-tial (ORP), as a substitute measure of redox status, was analyzed in male and female Group 1 PAH and healthy subjects. The profiles of 27 circulating cytokines were com-pared in 2 PAH groups exhibiting the highest and lowest quartile for plasma ORP, corre-lated with clinical parameters, and used to predict patient survival. The analysis of the PAH groups with the highest and lowest ORP revealed a correlation between elevated cytokine levels and increased oxidative stress in females. In contrast, in males, cytokine expressions were increased in the lower oxidative environment (except for IL-1b). Corre-lations of the increased cytokine expressions with PAH severity were highly sex -depen-dent and corresponded to the increase in PAH severity in males and less severe PAH in females. Machine learning algorithms trained on the combined cytokine and redox pro-files allowed the prediction of PAH mortality with 80% accuracy. We conclude that the profile of circulating cytokines in PAH patients is redox-and sex-dependent, suggesting the vital need to stratify the patient cohort subjected to anti-inflammatory therapies. Combined cytokine and/or redox profiling showed promising value for predicting the patients' survival.
引用
收藏
页码:1 / 18
页数:18
相关论文
共 82 条
  • [1] Necrosis Contributes to the Development of Hypertension in Male, but Not Female, Spontaneously Hypertensive Rats
    Abdelbary, Mahmoud
    Rafikova, Olga
    Gillis, Ellen E.
    Musall, Jacqueline B.
    Baban, Babak
    O'Connor, Paul M.
    Brands, Michael W.
    Sullivan, Jennifer C.
    [J]. HYPERTENSION, 2019, 74 (06) : 1524 - 1531
  • [2] MiOXSYS: a novel method of measuring oxidation reduction potential in semen and seminal plasma
    Agarwal, Ashok
    Sharma, Rakesh
    Roychoudhury, Shubhadeep
    Du Plessis, Stefan
    Sabanegh, Edmund
    [J]. FERTILITY AND STERILITY, 2016, 106 (03) : 566 - +
  • [3] T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension
    Austin, E. D.
    Rock, M. T.
    Mosse, C. A.
    Vnencak-Jones, C. L.
    Yoder, S. M.
    Robbins, I. M.
    Loyd, J. E.
    Meyrick, B. O.
    [J]. RESPIRATORY MEDICINE, 2010, 104 (03) : 454 - 462
  • [4] Y Not? Sex Chromosomes May Modify Sexual Dimorphism in Pulmonary Hypertension
    Austin, Eric D.
    Hamid, Rizwan
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (07) : 858 - 859
  • [5] Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease
    Batton, Kyle A.
    Austin, Christopher O.
    Bruno, Katelyn A.
    Burger, Charles D.
    Shapiro, Brian P.
    Fairweather, DeLisa
    [J]. BIOLOGY OF SEX DIFFERENCES, 2018, 9
  • [6] Oxidation-Reduction Potential as a Biomarker for Severity and Acute Outcome in Traumatic Brain Injury
    Bjugstad, Kimberly B.
    Rael, Leonard T.
    Levy, Stewart
    Carrick, Matthew
    Mains, Charles W.
    Slone, Denetta S.
    Bar-Or, David
    [J]. OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2016, 2016
  • [7] Human Immunodeficiency Virus-Associated Pulmonary Arterial Hypertension Considerations for Pulmonary Vascular Diseases in the Developing World
    Butrous, Ghazwan
    [J]. CIRCULATION, 2015, 131 (15) : 1361 - 1370
  • [8] Characterization of Connective Tissue Disease-Associated Pulmonary Arterial Hypertension From REVEAL Identifying Systemic Sclerosis as a Unique Phenotype
    Chung, Lorinda
    Liu, Juliana
    Parsons, Lori
    Hassoun, Paul M.
    McGoon, Michael
    Badesch, David B.
    Miller, Dave P.
    Nicolls, Mark R.
    Zamanian, Roham T.
    [J]. CHEST, 2010, 138 (06) : 1383 - 1394
  • [9] Professional killer cell deficiencies and decreased survival in pulmonary arterial hypertension
    Edwards, Adrienne L.
    Gunningham, Sarah P.
    Clare, Geoffrey C.
    Hayman, Matthew W.
    Smith, Mark
    Frampton, Christopher M. A.
    Robinson, Bridget A.
    Troughton, Richard W.
    Beckert, Lutz E. L.
    [J]. RESPIROLOGY, 2013, 18 (08) : 1271 - 1277
  • [10] Predicting outcomes in pulmonary arterial hypertension based on the 6-minute walk distance
    Farber, Harrison W.
    Miller, Dave P.
    McGoon, Michael. D.
    Frost, Adaani E.
    Benton, Wade W.
    Benza, Raymond L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2015, 34 (03) : 362 - 368